Natco Pharma announces a total investment of $25 million in eGenesis through its subsidiaries.
economy22 h ago
coda.news AI summary
- Natco Pharma’s Canadian subsidiary will invest $13.7 million in eGenesis.
- Natco Pharma USA LLC will invest $3 million in eGenesis.
- The investment is described as a total of $25 million through Natco Pharma’s subsidiaries.
- The report is attributed to The Hindu Business.
The Hindu BusinessRead original ↗